Maynard Ryan D 4
4 · Cara Therapeutics, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Maynard Ryan D
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-01+13,500→ 13,500 total
Footnotes (1)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "Award") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals.